These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

603 related articles for article (PubMed ID: 26295337)

  • 21. [Comparison of different massive parallel sequencing platforms for mutation profiling in formalin-fixed and paraffin-embedded samples].
    Jiang RR; Wang YJ; Teng XD; Xiao L; Bu H; Ye F
    Zhonghua Bing Li Xue Za Zhi; 2018 Aug; 47(8):591-596. PubMed ID: 30107663
    [No Abstract]   [Full Text] [Related]  

  • 22. GeneReader NGS System Is a Useful Sequencing Platform for Clinical Testing of
    Lee EJ; Kim HK; Ahn S; Lee YJ; Kim J; Lee SW; Lee JW; Lee W; Kim HS; Chun S; Son BH; Jung KH; Kim YM; Min WK; Ahn SH
    Ann Clin Lab Sci; 2020 Jan; 50(1):107-118. PubMed ID: 32161019
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Molecular analysis of BRCA1 and BRCA2 genes by next generation sequencing and ultrastructural aspects of breast tumor tissue.
    Mihalcea CE; Moroşanu AM; Murăraşu D; Puiu L; Cinca SA; Voinea SC; Mirancea N
    Rom J Morphol Embryol; 2017; 58(2):445-455. PubMed ID: 28730229
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Validation of a next generation sequencing assay for BRCA1, BRCA2, CHEK2 and PALB2 genetic testing.
    Sim WC; Lee CY; Richards R; Bettens K; Mottier V; Goh LL
    Exp Mol Pathol; 2020 Oct; 116():104483. PubMed ID: 32531196
    [TBL] [Abstract][Full Text] [Related]  

  • 25. The importance of analysis of long-range rearrangement of BRCA1 and BRCA2 in genetic diagnosis of familial breast cancer.
    Kwong A; Chen J; Shin VY; Ho JC; Law FB; Au CH; Chan TL; Ma ES; Ford JM
    Cancer Genet; 2015 Sep; 208(9):448-54. PubMed ID: 26271414
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Evaluation of a Next-Generation Sequencing Assay for BRCA1 and BRCA2 Mutation Detection.
    Capone GL; Putignano AL; Trujillo Saavedra S; Paganini I; Sestini R; Gensini F; De Rienzo I; Papi L; Porfirio B
    J Mol Diagn; 2018 Jan; 20(1):87-94. PubMed ID: 29061375
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Amplification of overlapping DNA amplicons in a single-tube multiplex PCR for targeted next-generation sequencing of BRCA1 and BRCA2.
    Schenk D; Song G; Ke Y; Wang Z
    PLoS One; 2017; 12(7):e0181062. PubMed ID: 28704513
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Development and analytical validation of a 25-gene next generation sequencing panel that includes the BRCA1 and BRCA2 genes to assess hereditary cancer risk.
    Judkins T; Leclair B; Bowles K; Gutin N; Trost J; McCulloch J; Bhatnagar S; Murray A; Craft J; Wardell B; Bastian M; Mitchell J; Chen J; Tran T; Williams D; Potter J; Jammulapati S; Perry M; Morris B; Roa B; Timms K
    BMC Cancer; 2015 Apr; 15():215. PubMed ID: 25886519
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Next-generation sequencing meets genetic diagnostics: development of a comprehensive workflow for the analysis of BRCA1 and BRCA2 genes.
    Feliubadaló L; Lopez-Doriga A; Castellsagué E; del Valle J; Menéndez M; Tornero E; Montes E; Cuesta R; Gómez C; Campos O; Pineda M; González S; Moreno V; Brunet J; Blanco I; Serra E; Capellá G; Lázaro C
    Eur J Hum Genet; 2013 Aug; 21(8):864-70. PubMed ID: 23249957
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Clinical validation of a next-generation sequencing screen for mutational hotspots in 46 cancer-related genes.
    Singh RR; Patel KP; Routbort MJ; Reddy NG; Barkoh BA; Handal B; Kanagal-Shamanna R; Greaves WO; Medeiros LJ; Aldape KD; Luthra R
    J Mol Diagn; 2013 Sep; 15(5):607-22. PubMed ID: 23810757
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Detection of BRCA1/2 large genomic rearrangement including BRCA1 promoter-region deletions using next-generation sequencing.
    Han E; Yoo J; Chae H; Lee S; Kim DH; Kim KJ; Kim Y; Kim M
    Clin Chim Acta; 2020 Jun; 505():49-54. PubMed ID: 32092317
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Development and validation of a variant detection workflow for BRCA1 and BRCA2 genes and its clinical application based on the Ion Torrent technology.
    Buzolin AL; Moreira CM; Sacramento PR; Oku AY; Fornari ARDS; Antonio DSM; Quaio CRDAC; Baratela WR; Mitne-Neto M
    Hum Genomics; 2017 Jun; 11(1):14. PubMed ID: 28651617
    [TBL] [Abstract][Full Text] [Related]  

  • 33. BRCA1-2 diagnostic workflow from next-generation sequencing technologies to variant identification and final report.
    Pilato B; Pinto R; De Summa S; Petriella D; Lacalamita R; Danza K; Paradiso A; Tommasi S
    Genes Chromosomes Cancer; 2016 Oct; 55(10):803-13. PubMed ID: 27225819
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Molecular analysis of the breast cancer genes BRCA1 and BRCA2 using amplicon-based massive parallel pyrosequencing.
    Michils G; Hollants S; Dehaspe L; Van Houdt J; Bidet Y; Uhrhammer N; Bignon YJ; Vermeesch JR; Cuppens H; Matthijs G
    J Mol Diagn; 2012 Nov; 14(6):623-30. PubMed ID: 23034506
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Analysis of the genetic diversity of influenza A viruses using next-generation DNA sequencing.
    Van den Hoecke S; Verhelst J; Vuylsteke M; Saelens X
    BMC Genomics; 2015 Feb; 16(1):79. PubMed ID: 25758772
    [TBL] [Abstract][Full Text] [Related]  

  • 36. A preliminary Quality Control (QC) for next generation sequencing (NGS) library evaluation turns out to be a very useful tool for a rapid detection of BRCA1/2 deleterious mutations.
    Concolino P; Costella A; Minucci A; Scaglione GL; Santonocito C; Salutari V; Scambia G; Zuppi C; Capoluongo E
    Clin Chim Acta; 2014 Nov; 437():72-7. PubMed ID: 25007954
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Next-generation sequencing of
    Nicolussi A; Belardinilli F; Mahdavian Y; Colicchia V; D'Inzeo S; Petroni M; Zani M; Ferraro S; Valentini V; Ottini L; Giannini G; Capalbo C; Coppa A
    PeerJ; 2019; 7():e6661. PubMed ID: 31065452
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Nonoptical massive parallel DNA sequencing of BRCA1 and BRCA2 genes in a diagnostic setting.
    Costa JL; Sousa S; Justino A; Kay T; Fernandes S; Cirnes L; Schmitt F; Machado JC
    Hum Mutat; 2013 Apr; 34(4):629-35. PubMed ID: 23315985
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Evaluation and optimisation of indel detection workflows for ion torrent sequencing of the BRCA1 and BRCA2 genes.
    Yeo ZX; Wong JC; Rozen SG; Lee AS
    BMC Genomics; 2014 Jun; 15(1):516. PubMed ID: 24962530
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Versatile ion S5XL sequencer for targeted next generation sequencing of solid tumors in a clinical laboratory.
    Mehrotra M; Duose DY; Singh RR; Barkoh BA; Manekia J; Harmon MA; Patel KP; Routbort MJ; Medeiros LJ; Wistuba II; Luthra R
    PLoS One; 2017; 12(8):e0181968. PubMed ID: 28767674
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 31.